Crossmark

Immunity and field efficacy of type 2-containing polio vaccines after cessation of trivalent oral polio vaccine: A population-based serological study in Pakistan

Crossref DOI link: https://doi.org/10.1016/j.jvacx.2020.100067

Published Print: 2020-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Voorman, Arie https://orcid.org/0000-0001-6242-7796
Habib, Muhammad Atif

Hussain, Imtiaz

Muhammad Safdar, Rana

Ahmed, Jamal A.

Weldon, William C. https://orcid.org/0000-0001-5624-6411
Ahmed, Imran

Umer, Muhammad

Partridge, Jeffrey

Soofi, Sajid Bashir https://orcid.org/0000-0003-4192-8406
Funding

Funding for this research was provided by:

Bill and Melinda Gates Foundation
License Information

Text and Data Mining valid from 2020-08-01

Text and Data Mining valid from 2020-08-01

Version of Record valid from 2020-05-03
More Information

This article is maintained by: Elsevier

Article Title: Immunity and field efficacy of type 2-containing polio vaccines after cessation of trivalent oral polio vaccine: A population-based serological study in Pakistan

Journal Title: Vaccine: X

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jvacx.2020.100067

Content Type: article

Copyright: © 2020 Elsevier Ltd.

Document is current

Any future updates will be listed below